Another major conclusion that can be drawn from our investigation is the distinction of the race-related expression of CRYβB2 and CRYβB2P1. First, our data highlight that expression of the pseudogene, CRYβB2P1, is associated with Black/African-American breast cancer patients compared to White and Asian patient samples, and CRYβB2P1expression levels are higher compared to CRYβB2 in all TCGA breast cancer samples. Here, CRYBB2 is linked to breast carcinoma.